Top searches

PL

Resources

B2RLaw advises Polish unicorn DocPlanner on its acquisition of MyDr

10/01/2023

B2RLaw has advised Polish unicorn DocPlanner on its acquisition of MyDr – DocPlanner’s first acquisition on the Polish market. Docplanner (operating in Poland under the ZnanyLekarz brand), the operator of an online SaaS platform for arranging medical appointments, has acquired MyDr which provides technological solutions to the medical sector, through its MyDr EDM and Dr100 software.

DocPlanner creates digital apps and software solutions for doctors, clinics, hospitals and patients to enable the healthcare system and patient journey to integrate seamlessly. The platform provides free doctor reviews and instant online appointment booking for patients through its online marketplaces. DocPlanner is used by approximately 85 million patients per month and more than 190,000 doctors globally in 13 countries. The company was founded in 2012 in Poland and now boasts a team of more than 2,600  based across offices in Warsaw, Barcelona, Istanbul, Rome, Mexico City, Curitiba and Bologna. It is backed by leading venture capital funds including Point Nine Capital, Goldman Sachs Asset Management and One Peak Partners, raising a total of approximately EUR 300 million to date.

DocPlanner has made nine acquisitions to date as part of its global expansion strategy, including TuoTempo in Italy, Doctoralia in Spain, and Eniyihekim (now Doktortakvimi) in Turkey, as well as German counterpart Jameda from Hubert Burda Media last year.

MyDr works with 47,000 doctors, and almost 2 million visits are arranged monthly via the company’s software. The company offers several services, including MyDr EDM for managing a medical practice; Dr100 for running dental offices and clinics; and the drNews information system for medical facilities.

B2RLaw advised DocPlanner (ZnanyLekarz) on all aspects of the transaction.

B2RLaw’s team was led by Senior Partner Rafał Stroiński and Partner Aleksandra Polak, and included Partner Marcin Huczkowski; Counsels Malwina Niczke–Chmura and Paulina Wyrostek; Senior Associates Krystyna Jakubowska and Teresa Pilecka–Juda; and Junior Associate Danyila Zubach.

JP Weber acted as Financial and Tax Advisor to DocPlanner on the transaction.

Rafał Stroiński advises, “DocPlanner was founded on the mission of making the healthcare experience more human. The company is considered to be the first Polish unicorn, and has been growing from strength-to-strength globally. With DocPlanner’s exponential international growth, we couldn’t be happier to support DocPlanner on this transaction – its first acquisition on the Polish market, which represents a sort of ‘return home’, and significantly increases DocPlanner’s Polish market share”.

Aleksandra Polak adds, “We would like to thank all those that worked on this transaction, particularly the DocPlanner/ZnanyLekarz team of Mariusz Gralewski, Peter Biało, Piotr Radecki, Zeno Capucci and Łukasz Łyczkowski”.

View more resources

Catch up on the very latest B2RLAW
announcements and news here.

10/01/2023

B2RLaw advises Polish unicorn DocPlanner on its acquisition of MyDr

B2RLaw has advised Polish unicorn DocPlanner on its acquisition of MyDr – DocPlanner’s first acquisition on the Polish market. Docplanner […]

MORE
02/01/2023

New Compliance 360 practice at B2RLaw

B2RLaw has established a multidisciplinary team whose aim is to support clients in monitoring and adapting their activities to the […]

MORE
28/11/2022

B2RLaw advises on the sale of award-winning Gdynia office complex

B2RLaw has advised the sellers (a Dutch company and Polish companies) on the sale of Łużycka Office Park (buildings A, […]

MORE
15/11/2022

B2RLaw advises SaaS-enabled B2B marketplace for the healthcare industry, Dentametr, on a pre-seed round with investors, which includes Octopus Ventures

B2RLaw has advised Dentametr and its founders on its pre-seed round capital raise with investors including leading investment fund Octopus […]

MORE
08/11/2022

B2RLaw advises Auxilius Pharma on capital raise to fuel groundbreaking growth to the US market

B2RLaw advised Auxilius Pharma Sp. z o.o. and its founders on a venture capital transaction related to the investment of […]

MORE
03/11/2022

B2RLaw advises Westcoast on merger to create EUR 5.5 billion ICT distributor

B2RLaw has advised the UK’s largest privately owned information and communications technology company Westcoast on Polish aspects of its merger […]

MORE

Get in touch

Not sure who to contact? Let us help you find the right lawyer.

This site uses cookies to improve your experience More information.

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close